32 Biosciences "Three Squared"
Peter Farmakis serves as the Chairman and Chief Executive Officer of Three Squared Biosciences since January 2023, where the focus is on microbiome science to prevent and treat diseases. Previously, Peter held the position of Chief Executive Officer at Gateway Biome and Covira, both microbiome-focused companies derived from The University of Chicago. Peter's earlier experience includes leadership roles at VitaHEAT® Medical, Abbott, and Johnson & Johnson, contributing to significant business growth in healthcare and medical devices. Peter's academic credentials include a Post-MBA from Northwestern University, a Post-MBA in Biopharma Innovation from Rutgers, an MBA in Marketing and Strategic Management, and a BA in Pre-Physical Therapy and Psychology from the University of Illinois Chicago.
This person is not in any teams
This person is not in any offices
32 Biosciences "Three Squared"
Revolutionizing Healthcare: Harnessing Microbiome Science to Prevent and Treat Disease We are taking a new approach to healthcare by using our field defining research to build clinically useful, validated, precision tools to diagnose and correct Dysbiosis, a central but underappreciated driver of disease.